GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Current Accrued Expense

K Pharma (TSE:4896) Current Accrued Expense : 円0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is K Pharma Current Accrued Expense?

K Pharma's Current Accrued Expense for the quarter that ended in Mar. 2024 was 円0 Mil.


K Pharma Current Accrued Expense Historical Data

The historical data trend for K Pharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Current Accrued Expense Chart

K Pharma Annual Data
Trend Dec21 Dec22 Dec23
Current Accrued Expense
- - -

K Pharma Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24
Current Accrued Expense Get a 7-Day Free Trial - - - - -

K Pharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


K Pharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of K Pharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


K Pharma (TSE:4896) Business Description

Traded in Other Exchanges
N/A
Address
7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032
K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines